We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
Cap. Flow
-$1.96B
Cap. Flow %
-1.67%
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101

Top Sells

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$607M
2
AAPL icon
Apple
AAPL
+$186M
3
MSFT icon
Microsoft
MSFT
+$139M
4
META icon
Meta Platforms (Facebook)
META
+$89.6M
5
NVDA icon
NVIDIA
NVDA
+$74.4M

Sector Composition

Rank Sector Weight
1 Technology 30.6%
2 Financials 12.67%
3 Consumer Discretionary 10.32%
4 Industrials 10.12%
5 Healthcare 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFFN icon
1726
Capitol Federal Financial
CFFN
$1.09B
$2.5M ﹤0.01%
350,505
+2,016
+0.6% +$14.4K
TRUP icon
1727
Trupanion
TRUP
$1.12B
$2.5M ﹤0.01%
97,528
+1,758
+2% +$52.5K
LION icon
1728
Lionsgate Studios
LION
$3.86B
$2.49M ﹤0.01%
259,366
-3,216
-1% -$29.7K
ITUB icon
1729
Itaú Unibanco
ITUB
$92.1B
$2.48M ﹤0.01%
296,477
-902
-0.3% -$7.55K
AGIO icon
1730
Agios Pharmaceuticals
AGIO
$2.14B
$2.48M ﹤0.01%
73,369
-784
-1% -$22.2K
TRST
1731
Trustco Bank Corp NY
TRST
$994M
$2.48M ﹤0.01%
56,675
-1,892
-3% -$82.8K
ASTH icon
1732
Astrana Health
ASTH
$1.8B
$2.47M ﹤0.01%
100,614
+4,720
+5% +$112K
CPF icon
1733
Central Pacific Financial
CPF
$1.02B
$2.47M ﹤0.01%
77,156
-6,506
-8% -$210K
SMMT icon
1734
Summit Therapeutics
SMMT
$9.93B
$2.46M ﹤0.01%
129,542
+8,201
+7% +$133K
VSTS icon
1735
Vestis
VSTS
$2.08B
$2.44M ﹤0.01%
310,318
-25,340
-8% -$185K
PRSU
1736
Pursuit Attractions and Hospitality Inc
PRSU
$1.47B
$2.43M ﹤0.01%
66,343
+541
+0.8% +$19.3K
IMVT icon
1737
Immunovant
IMVT
$8B
$2.42M ﹤0.01%
97,493
+10,646
+12% +$276K
STAA icon
1738
STAAR Surgical
STAA
$1.09B
$2.42M ﹤0.01%
129,257
-9,395
-7% -$179K
BP icon
1739
BP
BP
$110B
$2.42M ﹤0.01%
51,397
+3,255
+7% +$128K
CACC icon
1740
Credit Acceptance
CACC
$5.77B
$2.41M ﹤0.01%
5,699
-402
-7% -$190K
DBD icon
1741
Diebold Nixdorf
DBD
$3.13B
$2.41M ﹤0.01%
31,908
-799
-2% -$58.8K
GRAL
1742
GRAIL Inc
GRAL
$2.8B
$2.4M ﹤0.01%
46,495
-600
-1% -$46.5K
RSI icon
1743
Rush Street Interactive
RSI
$3.16B
$2.4M ﹤0.01%
110,241
-1,242
-1% -$23.8K
LGN
1744
Legence Corp
LGN
$4.57B
$2.39M ﹤0.01%
42,283
+1,360
+3% +$68.5K
THRM icon
1745
Gentherm
THRM
$1.3B
$2.38M ﹤0.01%
85,852
-1,159
-1% -$37.8K
MATW icon
1746
Matthews International
MATW
$895M
$2.38M ﹤0.01%
92,243
+1,702
+2% +$44.6K
NX icon
1747
Quanex
NX
$883M
$2.38M ﹤0.01%
132,286
-1,300
-1% -$24.5K
HAFC icon
1748
Hanmi Financial
HAFC
$948M
$2.34M ﹤0.01%
88,794
-327
-0.4% -$8.8K
CLB icon
1749
Core Laboratories
CLB
$510M
$2.34M ﹤0.01%
139,134
+4,193
+3% +$75K
SONY icon
1750
Sony
SONY
$133B
$2.33M ﹤0.01%
112,578
+5,053
+5% +$113K

Similar funds

RhumbLine Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
  • RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
  • RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
  • RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
  • RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
  • RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.